Description
Entekor -1 mg (90 Tablets)
Composition: Entacavir -1 mg
Classification: Hepatitis B medicine
Entekor: Doctor-Trusted Treatment for Hepatitis B
Entekor is a globally prescribed medicine for Hepatitis B, trusted by doctors and patients in over 50 countries. It stands out as a reliable, affordable, and effective solution for long-term management of Hepatitis B.
Aprazer Healthcare: Innovating Global Hepatology Care
As a pioneer in Hepatology, Aprazer Healthcare leads the way in manufacturing WHO-GMP certified medicines that meet global quality standards. With a commitment to therapeutic efficacy and patient safety, we deliver all WHO-listed essential hepatitis medications across the world — ensuring access to high-quality treatment at the most affordable prices.
What is Entekor?
Entekor is an Hepatitis B medicine, antiviral drug that mimics the DNA bases.
How does Entekor work?
It enters viral DNA, inhibits polymerase, halting chain elongation and propagation.
Uses of Entekor
- • It is used in Chronic Hepatitis B
- • Preventive care to prevent the recurrence of Hepatitis B
Benefits
- • Suppress viral load
- • Can be used after a liver transplant
- • Can be used in HIV co-infection
- • In advanced liver disorders
Common Side Effects
- • Nausea
- • Dizziness
- • Headache
- • Digestive issues
- • Tiredness
- • Diarrhea
Serious Side Effects
- • Lactic acidosis – lactic acid buildup in blood, causing muscle pain, unusual tiredness
- • Enlarged fatty liver
- • Hepatitis B flare-ups
- • HIV co-infection may worsen
- • Renal dysfunctions
Precautions
To be used cautiously in patients with –
- • Kidney disorder
- • Liver dysfunction
- • Liver transplant
- • HIV-co-infection
- • Pediatric function
- • Elderly patient
Contraindications
- • Allergy or hypersensitivity to Entacavir or any other drug component
- • Breastfeeding mothers
- • Pregnant women
Warning
Use under a doctor’s prescription.
Important Safety and Monitoring Instructions
Monitor –
- • Hepatic function
- • Renal function
- • Bone mineral density
- • Viral load and HIV co-infections